0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Viewpoint |  May 15, 2013
Cost Consequences of the 340B Drug Discount Program
Rena M. Conti, PhD; Peter B. Bach, MD, MAPP
JAMA. 2013;309(19):1995-1996. doi:10.1001/jama.2013.4156.
JAMA | 
Visualizing Health Policy |  May 15, 2013 FREE
The Role of Medicaid and Medicare in Women's Health Care
Kaiser Family Foundation*
JAMA. 2013;309(19):1984. doi:10.1001/jama.2013.4269.
JAMA | 
News From the Centers for Disease Control and Prevention |  May 15, 2013
Finding Ways to Cut Drug Costs
JAMA. 2013;309(19):1986. doi:10.1001/jama.2013.4949.
JAMA | 
Capitol Health Call |  May 08, 2013
Medicare Waste and Abuse
Mike Mitka, MSJ
JAMA. 2013;309(18):1885. doi:10.1001/jama.2013.4941.
JAMA | 
Viewpoint |  May 08, 2013
Investments in Infrastructure for Diverse Research Resources and the Health of the Public
Bruce M. Psaty, MD, PhD; Eric B. Larson, MD, MPH
JAMA. 2013;309(18):1895-1896. doi:10.1001/jama.2013.3445.
JAMA | 
Viewpoint |  May 08, 2013
Connecting to Health Insurance Coverage
Howard Koh, MD, MPH; Marilyn Tavenner, RN, MHA
JAMA. 2013;309(18):1893-1894. doi:10.1001/jama.2013.3469.
JAMA | 
Viewpoint |  May 08, 2013
Severing the Link Between Coverage Policy and the US Preventive Services Task Force
Steven H. Woolf, MD, MPH; Doug Campos-Outcalt, MD, MPA
JAMA. 2013;309(18):1899-1900. doi:10.1001/jama.2013.3448.
JAMA Internal Medicine | 
Viewpoint |  May 06, 2013 ONLINE FIRST
Coverage With Evidence Development for Medicare Beneficiaries:  Challenges and Next Steps
Gregory W. Daniel, PhD, MPH; Erin K. Rubens, MPH, MBA; Mark McClellan, MD, PhD
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.6793.
JAMA Internal Medicine | 
Invited Commentary |  May 06, 2013 ONLINE FIRST
Supporting High-Value Part D Medicare Choices for Low-Income Beneficiaries:  Comment on “Cognition and Take-up of Subsidized Drug Benefits by Medicare Beneficiaries”
Karen L. Margolis, MD, MPH
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.6809.
JAMA Internal Medicine | 
Original Investigation |  May 06, 2013 ONLINE FIRST
Cost Consideration in the Clinical Guidance Documents of Physician Specialty Societies in the United States
Jennifer A. T. Schwartz, MD; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2013;():1-7. doi:10.1001/jamainternmed.2013.817.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Viewpoint  |  April 22, 2013
Cost Consequences of the 340B Drug Discount Program
Rena M. Conti, PhD; Peter B. Bach, MD, MAPP
JAMA
Visualizing Health Policy  |  May 15, 2013
The Role of Medicaid and Medicare in Women's Health Care
Kaiser Family Foundation*
JAMA
News From the Centers for Disease Control and Prevention  |  May 15, 2013
Finding Ways to Cut Drug Costs
JAMA
Capitol Health Call  |  May 08, 2013
Medicare Waste and Abuse
Mike Mitka, MSJ
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems